We have added further discussion relating to the pathogenesis of neurodevelopmental disorders arising from GRIN2B mutations in lines 765-771 of the manuscript.
3) A scheme summarizing how different molecular defects can converge on similar NMDAR-mediated EPSCs would be helpful in the discussion 4) A small commentary on the possible functional significance of the identified mutation properties for the pathogenesis of certain diseases would be interesting.